Ocular myasthenic syndrome after interferon therapy for chronic hepatitis

Neuro-Ophthalmology

Volumn 16, Issue 3, 1996, Pages 197-202

  Mimura, Osamu ^a   Iwasaki, Yoshihide ^a   Shimo oku, Masashi ^a   Kawara, Akira ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Kawara Clinic   (Japan)

Author keywords

Eye movement disorders; Interferon; Myasthenic syndrome; Ptosis; Side effect

Indexed keywords

ALPHA2 INTERFERON;

AGED; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; FEMALE; HUMAN; MYASTHENIA;

EID: 0029999880     PISSN: 01658107     EISSN: None     Source Type: Journal    
DOI: 10.3109/01658109609009682     Document Type: Article

References (14)

1. Rohatiner AZS, Prior PF, Burton AC, Smith AT, Balkwii FR, Lister TA. Central nervous system of interferon. Br J Cancer 1983; 47:419-422.
2. Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991; 41:672-676.
3. Meimsky O, Nisipeanu P, Loewenstein A, et al. Interferon-related cortical blindness. Cancer Chemother Pharmacol 1992; 29:329-330.
4. Quesada JR, Hersh EM, Gutteman JV. Clinical toxicity of interferons in cancer patients. J Clin Oncol 1986; 4:234-243.
5. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111:350-356.
6. Bauherz G, Soeur M, Lustman F. Oculomotor nerve paralysis induced by alpha-II-interferon. Acta Neurol Belg 1990; 90:111-114.
7. Riedel RR, Schmitt A, Hartmann A. Ocular pseudo-myasthenic reaction induced by interferon in an AIDS patient. Klin Wochenschr 1991; 69:930-931.
8. Pacifici L, Passarelli F, Papa G, Cannone L. Acute third cranial nerve ophthalmoplegia: possible pathogenesis from alpha-II-interferon treatment. Ital J Neurol Sci 1993; 14:579-580.
9. Stålberg E, Sanders DB. Electrophysiological tests of neuromuscular transmission. In: Stålberg E, Young RR, editors. Clinical Neuro-physiology. London: Butterworths, 1981; 88-116.
10. Glaser JS, Bachynski B. Disorders of the neuromuscular junction and ocular myopathies. In: Glaser JS, editor. Neuro-ophthalmology, 2nd edition. Philadelphia: J.B. Lippincott, 1990; 392-406.
11. Uyama J, Mimura O, Ikeda N, Shimo-oku M. Single-fiber electromyography of extraocular muscles in myasthenia gravis. Neuro-opthalmology 1993; 13:253-261.
12. Kelly JJ, Dauble JR, Lennon VA, Howard FM, Younge BR. The laboratory diagnostic of mild myasthenia gravis. Ann Neurol 1982; 12:238-242.
13. Miller NR. Myopathies and disorders of neuromuscular transmission. In: Walsh and Hoyt's Clinical Neuro-ophthalmology, 4th edition. Baltimore: Williams & Wilkins, 1985; 785-891.
14. Vial T, Descotes J. Clinical toxicity of the interferons. Drug Safety 1994; 10:115-150.